Oruka Therapeutics, Inc. (ORKA) stock
ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
$96.32−2.92 (-2.94%)
Close on Nov 17, 2026Market cap $6.38BP/E –Yield –
Oruka Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Oruka Therapeutics's total assets was $1.14B at Jun 30, 2026. For fiscal 2025 it was $488.62M, up 23.4% from the year before. Over ten years it grew 28.6% a year on average. The highest annual figure on record is $488.62M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $488.62M | +23.4% |
| FY2024 | Dec 31, 2024 | $396.02M | +946.0% |
| FY2023 | Dec 31, 2023 | $37.86M | -12.1% |
| FY2022 | Dec 31, 2022 | $43.09M | -21.6% |
| FY2021 | Dec 31, 2021 | $54.92M | +8.9% |
| FY2020 | Dec 31, 2020 | $50.43M | +490.8% |
| FY2019 | Dec 31, 2019 | $8.54M | +25.1% |
| FY2018 | Dec 31, 2018 | $6.83M | -44.8% |
| FY2017 | Dec 31, 2017 | $12.37M | -49.8% |
| FY2016 | Dec 31, 2016 | $24.63M | -37.8% |
| FY2015 | Dec 31, 2015 | $39.57M | +145.3% |
| FY2014 | Dec 31, 2014 | $16.13M | -5.6% |
| FY2013 | Dec 31, 2013 | $17.08M | +431.9% |
| FY2012 | Dec 31, 2012 | $3.21M | -50.6% |
| FY2011 | Dec 31, 2011 | $6.50M | -20.3% |
| FY2010 | Dec 31, 2010 | $8.16M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.14B | +218.8% |
| Q1 FY2026 | Mar 31, 2026 | $504.48M | +33.8% |
| Q4 FY2025 | Dec 31, 2025 | $488.62M | +23.4% |
| Q3 FY2025 | Sep 30, 2025 | $509.25M | +23.0% |
| Q2 FY2025 | Jun 30, 2025 | $357.42M | +956.1% |
| Q1 FY2025 | Mar 31, 2025 | $377.11M | +927.4% |
| Q4 FY2024 | Dec 31, 2024 | $396.02M | +946.0% |
| Q3 FY2024 | Sep 30, 2024 | $414.09M | +956.8% |
| Q2 FY2024 | Jun 30, 2024 | $33.84M | -17.6% |
| Q1 FY2024 | Mar 31, 2024 | $36.71M | -12.7% |
| Q4 FY2023 | Dec 31, 2023 | $37.86M | -12.1% |
| Q3 FY2023 | Sep 30, 2023 | $39.18M | -12.9% |
| Q2 FY2023 | Jun 30, 2023 | $41.08M | -14.6% |
| Q1 FY2023 | Mar 31, 2023 | $42.06M | -17.6% |
| Q4 FY2022 | Dec 31, 2022 | $43.09M | -21.6% |
| Q3 FY2022 | Sep 30, 2022 | $44.97M | -25.3% |
| Q2 FY2022 | Jun 30, 2022 | $48.10M | -26.4% |
| Q1 FY2022 | Mar 31, 2022 | $51.01M | -26.3% |
| Q4 FY2021 | Dec 31, 2021 | $54.92M | +8.9% |
| Q3 FY2021 | Sep 30, 2021 | $60.19M | +15.8% |
| Q2 FY2021 | Jun 30, 2021 | $65.34M | +775.7% |
| Q1 FY2021 | Mar 31, 2021 | $69.18M | +710.5% |
| Q4 FY2020 | Dec 31, 2020 | $50.43M | +406.9% |
| Q3 FY2020 | Sep 30, 2020 | $51.98M | +400.4% |
| Q1 FY2020 | Mar 31, 2020 | $7.46M | -13.3% |
| Q4 FY2019 | Dec 31, 2019 | $8.54M | +25.1% |
| Q3 FY2019 | Sep 30, 2019 | $9.95M | +17.8% |
| Q2 FY2019 | Jun 30, 2019 | $10.39M | +3.2% |
| Q1 FY2019 | Mar 31, 2019 | $8.61M | -32.7% |
| Q4 FY2018 | Dec 31, 2018 | $6.83M | -44.8% |
| Q3 FY2018 | Sep 30, 2018 | $8.45M | -50.1% |
| Q2 FY2018 | Jun 30, 2018 | $10.07M | -41.8% |
| Q1 FY2018 | Mar 31, 2018 | $12.79M | -37.9% |
| Q4 FY2017 | Dec 31, 2017 | $12.37M | -49.8% |
| Q3 FY2017 | Sep 30, 2017 | $16.92M | -41.0% |
| Q2 FY2017 | Jun 30, 2017 | $17.30M | -47.0% |
| Q1 FY2017 | Mar 31, 2017 | $20.59M | – |
| Q4 FY2016 | Dec 31, 2016 | $24.63M | – |
| Q3 FY2016 | Sep 30, 2016 | $28.68M | – |
| Q2 FY2016 | Jun 30, 2016 | $32.64M | – |
See a number that looks wrong?